Press release

TFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023

FORT WORTH, Texas, Nov. 07, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that management will host a conference call to discuss the financial results for the third quarter of 2023 and provide an update on recent corporate and clinical developments on Tuesday, November 14, 2023, at 4:30 PM ET. A question-and-answer session with investors will follow management's remarks.

Conference Call and Webcast Information

The Company will host a conference call on Tuesday, November 14, 2023, at 4:30 PM ET to review the clinical, corporate and financial highlights. To participate in the conference call, either join the webcast or dial one of the following numbers prior to the start of the call:

  Domestic Dial-In Number: Toll-Free: 1-888-886-7786
  International Dial-In Number: 1-416-764-8658
  Conference ID: 08897681
  Call me™: LINK (will be made active 15 minutes prior to the scheduled start time)
   

The call will also be webcast live and can be accessed on TFF Pharmaceuticals' Website, https://tffpharma.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1637201&tp_key=3b92c57ca8. Please access the Company's website at least 15 minutes ahead of the conference to register, download, and install any necessary audio software. The conference call will also be available for replay for one month on the Company's website in the Events Calendar of the Investors section.

ABOUT TFF PHARMACEUTICALS' THIN FILM FREEZING (TFF) TECHNOLOGY TFF Pharmaceuticals' proprietary Thin Film Freezing (TFF) technology allows for the transformation of both existing compounds and new chemical entities into dry powder formulations exhibiting unique characteristics ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner
Trending

More to read